Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2–12 years: a double‐blind, randomized, placebo‐controlled trial

R. Stainer,S. Matthews,S. H. Arshad,S. McDonald,J. Robinson,C. Schapira,K.D. Foote,M. Baird-Snell,T. Gregory,I. Pollock,M. Stevens,A. Edwards
DOI: https://doi.org/10.1111/j.1365-2133.2004.06303.x
IF: 11.113
2005-02-01
British Journal of Dermatology
Abstract:Background  Atopic dermatitis (AD) is a common inflammatory allergic disease of children. The primary anti‐inflammatory therapy is topical steroids. An effective treatment without the topical and systemic adverse effects of corticosteroids would be useful. Topical formulations of sodium cromoglicate have been researched in the past, but without consistent results. We report a trial of a new aqueous skin lotion of sodium cromoglicate (Altoderm) in children with AD.
What problem does this paper attempt to address?